These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22259028)

  • 1. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
    Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
    Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
    Rodamer M; Elsinghorst PW; Kinzig M; Gütschow M; Sörgel F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):695-706. PubMed ID: 21367676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
    Marangon E; Buzzo M; Posocco B; Gagno S; Zanchetta M; Iacuzzi V; Poetto AS; Guardascione M; Giodini L; Toffoli G
    J Pharm Biomed Anal; 2020 Feb; 179():112949. PubMed ID: 31784210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Minkin P; Zhao M; Chen Z; Ouwerkerk J; Gelderblom H; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):84-8. PubMed ID: 18823825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
    Qiu F; Bian W; Li J; Ge Z
    Biomed Chromatogr; 2013 May; 27(5):615-21. PubMed ID: 23108983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
    de Bruijn P; Sleijfer S; Lam MH; Mathijssen RH; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2010 Mar; 51(4):934-41. PubMed ID: 19931354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies.
    Chen X; Wang Z; Liu M; Liao M; Wang X; Du H; Chen J; Yao M; Li Q
    Biomed Chromatogr; 2015 May; 29(5):679-88. PubMed ID: 25294592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HPLC method for simultaneous quantification of sunitinib and its active metabolite, SU12662, using hydrophilic interaction chromatography principle.
    Gurjar M; Mehta P; Sharma J; Patil S; Kulkarni P; Patil A; Nookala M; Joshi A; Gota V
    Bioanalysis; 2020 Jan; 12(2):75-85. PubMed ID: 31928228
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous determination of subutinib and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetic study.
    Ding LK; Yang L; Chen SN; Li JK; Wen AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():22-6. PubMed ID: 26253807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
    Andriamanana I; Gana I; Duretz B; Hulin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():83-91. PubMed ID: 23562906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry.
    Musijowski J; Piórkowska E; Rudzki PJ
    J Sep Sci; 2014 Oct; 37(19):2652-8. PubMed ID: 25044855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma.
    Blanchet B; Saboureau C; Benichou AS; Billemont B; Taieb F; Ropert S; Dauphin A; Goldwasser F; Tod M
    Clin Chim Acta; 2009 Jun; 404(2):134-9. PubMed ID: 19341717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients.
    Zhao J; Yan D; Li Y; Xu X; Li F; Zhang S; Jin J; Qiu F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124100. PubMed ID: 38547701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma.
    Wiegand R; Wu J; Sha X; LoRusso P; Heath E; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1460-4. PubMed ID: 19349217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma.
    Zhao M; Rudek MA; Mnasakanyan A; Hartke C; Pili R; Baker SD
    J Pharm Biomed Anal; 2007 Jan; 43(2):784-7. PubMed ID: 16971082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application.
    Zhou Q; Gallo JM
    J Pharm Biomed Anal; 2010 Mar; 51(4):958-64. PubMed ID: 19896317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of total and unbound ribociclib in human plasma and brain tumor tissues using liquid chromatography coupled with tandem mass spectrometry.
    Bao X; Wu J; Sanai N; Li J
    J Pharm Biomed Anal; 2019 Mar; 166():197-204. PubMed ID: 30660034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma.
    Zhang X; Zhao M; Rudek MA; He P; Vogelstein B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):217-22. PubMed ID: 17307035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.